Abstract:Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. These tumors are present in almost all case mutations of KIT-CD117. When located in different places other than the gastrointestinal tract they are called extragastrointestinal stromal tumors (EGISTs). We present the case of a 70-year old patient with abdominal pain. Computed tomography (C/T) and ultrasound (U/S) indicated the existence of a hypoechoic enlarged 9.6 x 10 cm uterus due to leiomyoma. The clinical… Show more
“…Arising from interstitial cells of Cajal, GISTs most commonly occur in the stomach (60%), jejunum/ileum (30%), duodenum (4%-5%), rectum (4%), and colon/appendix (1%-2%) (2). These rare tumors have been described outside the intestinal tract, in the omentum or retroperitoneum (7). EGISTs are also found in gynecologic organs such as the vagina and fallopian tubes; however, there are only 12 other gynecologic cases reported, 3 of which are described in the rectovaginal septum, making this location for an EGIST very unique (Table 1) (1,7-13).…”
Section: Discussionmentioning
confidence: 96%
“…After performing a literature search using MEDLINE from January 1, 1950 to August 1, 2008 using the search terms ''leiomyoscaroma, GIST, gastrointestinal stromal tumor, EGIST, extra-gastrointestinal stromal tumor, rectovaginal septum, vagina, vulva, perineum, uterus, ovary, and gynecology,'' we found 3 other cases of EGIST arising in the rectovaginal septum that were reported in the English literature (Table 1) (1,(7)(8)(9)(10)(11)(12)(13). To our knowledge, this represents the 13th case of EGIST reported in the gynecologic tract and the fourth case described in the rectovaginal septum.…”
Extra-gastrointestinal stromal tumors (EGISTs) are rare, and may have similar histologic appearance to leiomyosarcomas. Thus, these tumors are often misdiagnosed when occurring in gynecologic organs. We present the fourth case of EGIST occurring in the rectovaginal septum and a review of the literature. A 56-year-old woman presented with a rectovaginal mass that was initially diagnosed as leiomyosarcoma and was treated with resection and adjuvant radiation. She presented with recurrence 4 years later and underwent a second resection. After a 5-year disease-free interval, she experienced a second recurrence and after resection was diagnosed with recurrent EGIST. EGISTs are rare but should be considered in the differential diagnosis of spindle-cell neoplasms located in or near the gynecologic tract.
“…Arising from interstitial cells of Cajal, GISTs most commonly occur in the stomach (60%), jejunum/ileum (30%), duodenum (4%-5%), rectum (4%), and colon/appendix (1%-2%) (2). These rare tumors have been described outside the intestinal tract, in the omentum or retroperitoneum (7). EGISTs are also found in gynecologic organs such as the vagina and fallopian tubes; however, there are only 12 other gynecologic cases reported, 3 of which are described in the rectovaginal septum, making this location for an EGIST very unique (Table 1) (1,7-13).…”
Section: Discussionmentioning
confidence: 96%
“…After performing a literature search using MEDLINE from January 1, 1950 to August 1, 2008 using the search terms ''leiomyoscaroma, GIST, gastrointestinal stromal tumor, EGIST, extra-gastrointestinal stromal tumor, rectovaginal septum, vagina, vulva, perineum, uterus, ovary, and gynecology,'' we found 3 other cases of EGIST arising in the rectovaginal septum that were reported in the English literature (Table 1) (1,(7)(8)(9)(10)(11)(12)(13). To our knowledge, this represents the 13th case of EGIST reported in the gynecologic tract and the fourth case described in the rectovaginal septum.…”
Extra-gastrointestinal stromal tumors (EGISTs) are rare, and may have similar histologic appearance to leiomyosarcomas. Thus, these tumors are often misdiagnosed when occurring in gynecologic organs. We present the fourth case of EGIST occurring in the rectovaginal septum and a review of the literature. A 56-year-old woman presented with a rectovaginal mass that was initially diagnosed as leiomyosarcoma and was treated with resection and adjuvant radiation. She presented with recurrence 4 years later and underwent a second resection. After a 5-year disease-free interval, she experienced a second recurrence and after resection was diagnosed with recurrent EGIST. EGISTs are rare but should be considered in the differential diagnosis of spindle-cell neoplasms located in or near the gynecologic tract.
“…EGISTs in the gynaecological tract are rare,3 4 20–22 but may be more common than is recognised. As far as we are aware, only two cases of primary uterine EGIST had been reported in the literature, both of which have had molecular confirmation 3 4. Interestingly, in one of these studies, normal uteri used as controls contained CD117 positive Cajal-like mesenchymal cells scattered in the myometrium 3.…”
Since GISTs have rarely been described as primary uterine neoplasms, the presence of DOG1 immunoreactivity in a uterine leiomyosarcoma may result in diagnostic confusion, and a panel of markers is necessary for diagnosis. Uterine leiomyosarcomas should be added to the list of mesenchymal neoplasms which may be DOG1 positive.
“…There are usually mutations in either KIT-CD117 or PDGF (platelet-derived growth factor) with these kind of mesenchymal tumors [9]. 95% of GISTs are found with CD117 somatic mutation.…”
Extragastrointestinal stromal tumors (EGISTs) are mesenchymal neoplasms without connection to the gastrointestinal tract. Gastrointestinal stromal tumors (GISTs) and EGIST are similar according to their clinicopathologic and histomorphologic features. Both of them most often express immunoreactivity for CD-117, a c-kit proto-oncogene protein. The coexistence of GIST and pregnancy is very rare, with only two cases reported in the literature. In this paper, we presented the first EGIST case during pregnancy in the literature.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.